The efficacy of the utmost suggested dose of pregabalin capsules with the administration of neuropathic discomfort connected to diabetic peripheral neuropathy was proven in 3 double-blind, placebo-controlled, multicenter scientific tests with thrice on a daily basis dosing, two of which researched the maximum proposed dose. Patients were enrolled w